This is Thomas Sullivan - Policy & Medicine Writing Staff's Typepad Profile.
Join Typepad and start following Thomas Sullivan - Policy & Medicine Writing Staff's activity
Join Now!
Already a member? Sign In
Thomas Sullivan - Policy & Medicine Writing Staff
Columbia, Maryland
Former political consultant who founded Rockpointe, Inc. a bio-medical education company in 1995.
Interests: marketing, politics, baseball, cycling, medicine, university of florida sports, medical education, track and cross country, driving kids to various practices
Recent Activity
Image
In June 2016, at the AMA House of Delegates meeting in Chicago, one of the topics discussed was Maintenance of Certification. However, what was not mentioned in the AMA press (or really, any other press) was the fact that the... Continue reading
Posted yesterday at Policy and Medicine
Image
The Annual Pharmaceutical and Medical Device Compliance Congress is an important opportunity for industry compliance professionals and regulators to exchange information and learn from one another. This year was no exception and this article briefly recaps the highlights from the... Continue reading
Posted yesterday at Policy and Medicine
Image
Nearly three years after its initial introduction, the 21st Century Cures Act has finally passed both houses of the Congress, and is expected to be signed by President Obama relatively quickly. This bill represents one of the few truly bipartisan... Continue reading
Posted 2 days ago at Policy and Medicine
Image
On October 1, 2016, the ICD-10 coding grace period came to an end and physicians are no longer able to submit unspecified codes on certain Medicare claims. With the end of the grace period just behind us, it is too... Continue reading
Posted 3 days ago at Policy and Medicine
Image
In late November, a report was released that focused on money in medicine, and the top thirty drugs that were associated with pharmaceutical industry payments to Oregon doctors. Interestingly, the top thirty list did not include many drugs that are... Continue reading
Posted 4 days ago at Policy and Medicine
Image
In part two of our MACRA analysis, we continue our look at MIPS and evaluate the APM pathway of MACRA’s new quality payment program. Small Practice Considerations Exemption Key finalized policies include a small practice-friendly low volume threshold. In 2017,... Continue reading
Posted 5 days ago at Policy and Medicine
Image
On April 20, 2016, the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) convened a Leadership Summit for Jointly Accredited Providers at the ACCME’s offices in Chicago.... Continue reading
Posted Dec 2, 2016 at Policy and Medicine
Image
Ever since the election, there has been much hubbub about who President-Elect Donald Trump will choose to fill important cabinet positions in his administration. Step by step, we are slowly seeing the Cabinet be put together. Recently, Mr. Trump announced... Continue reading
Posted Dec 1, 2016 at Policy and Medicine
Image
We previously wrote about the updated version of the 21st Century Cures bill – one that we, along with many others, thought would pass both the House and the Senate with minimal edits, if any. However, the new bill no... Continue reading
Posted Nov 30, 2016 at Policy and Medicine
Image
When lawmakers head back to Washington, D.C. this week, one of the votes they have ahead of themselves is the 21st Century Cures bill, legislation that is intended to spur the development of new medical treatments. The bill was updated... Continue reading
Posted Nov 29, 2016 at Policy and Medicine
Image
In its final MACRA rule, CMS significantly revamped the physician pay rule to make it easy for physicians to avoid penalties and to earn bonuses, and the agency is leaving the final rule open for comment to make it easier... Continue reading
Posted Nov 28, 2016 at Policy and Medicine
Image
In early October, Chicago mayor Rahm Emanuel announced a “series of efforts to combat heroin and opioid addiction throughout Chicago.” According to a press release on the City of Chicago’s website, “these proposed efforts would increase the City’s annual investment... Continue reading
Posted Nov 23, 2016 at Policy and Medicine
Image
The Department of Justice (DOJ) recently announced a settlement with Tenet Healthcare Corporation and several subsidiaries, resolving criminal charges and civil claims relating to a scheme to defraud the United States and to pay kickbacks in exchange for patient referrals.... Continue reading
Posted Nov 22, 2016 at Policy and Medicine
Image
The Medicare Payment Advisory Commission meets publicly in Washington, D.C. to discuss various Medicare issues and policy questions, as well as to develop and approve reports and recommendations to Congress. During the November public meeting, Ariel Winter and Amy Phillips... Continue reading
Posted Nov 21, 2016 at Policy and Medicine
Image
The FDA OPDP issued enforcement letters have been on a steep decline since 2010. This article examines the numbers of OPDP letters issued, they were issued for, and what it may mean for the compliance industry. Tom Abrams, FDA’s Director... Continue reading
Posted Nov 21, 2016 at Policy and Medicine
Image
On October 27, 2016, the Medicaid and CHIP Payment and Access Commission’s (MACPAC) October public meeting, the Commission reviewed strategies for prescription drug cost containment in Medicaid. The discussion was preliminary and acted more as a brainstorming session for Commissioners... Continue reading
Posted Nov 18, 2016 at Policy and Medicine
Image
Increasingly creative methods are being used by big pharma to increase sales. Drug manufacturers are donating billions of dollars to not-for-profit organizations that fund co-pay assistance programs for patients. Pharmaceutical company profits are through the roof, and these not-for-profit organizations... Continue reading
Posted Nov 18, 2016 at Policy and Medicine
Image
Recently, the ranking members of the Judiciary and Finance Committees, Senators Patrick Leahy and Ron Wyden, respectively, raised concerns about Department of Justice (DOJ) oversight of opioid distributors. In a letter sent to Attorney General Loretta Lynch, the senators raised... Continue reading
Posted Nov 17, 2016 at Policy and Medicine
Image
Leaders of three congressional committees have raised concerns about how the Centers for Medicare and Medicaid Services investigates Medicare fraud. Senator Orrin Hatch (chairman of the Senate Finance Committee), along with Representatives Kevin Brady, Fred Upton, Peter Roskam, Tim Murphy,... Continue reading
Posted Nov 16, 2016 at Policy and Medicine
Image
Handling whistleblowers is one of the biggest challenges facing most compliance officers. Furthermore, recent actions taken by the SEC are de facto policy pronouncements expanding the range of whistleblower risks compliance officers face. This article will review the three primary... Continue reading
Posted Nov 16, 2016 at Policy and Medicine
Image
After almost fifteen months of campaigning, polls, and 24/7 election coverage of “he-said-she-said,” we finally have our answer: President-Elect Donald Trump. Regardless of where you fall politically, or who you voted for, the top question on everyone’s mind is what... Continue reading
Posted Nov 15, 2016 at Policy and Medicine
Image
The United States Health and Human Services (HHS) Office of Inspector General (OIG) recently released its 2017 Work Plan, which summarizes new and ongoing reviews and activities that OIG plans to pursue with respect to HHS programs and operations during... Continue reading
Posted Nov 14, 2016 at Policy and Medicine
Image
There are some strong indicators to suggest that 2016 is on track to be a real banner year regarding Foreign Corrupt Practices Act (“FCPA”) enforcement and qui tam actions. One of the most notable indicators is that FCPA enforcement for... Continue reading
Posted Nov 14, 2016 at Policy and Medicine
Image
We recently wrote about Proposition 61 in California – a measure that would have required drug makers to provide large discounts to state agencies that serve HIV patients, retirees, inmates, and low-income residents. On Election Day, after months of campaigns... Continue reading
Posted Nov 11, 2016 at Policy and Medicine
Image
GlaxoSmithKline (“GSK”) reached a settlement with the Chinese government in 2014 related to bribes and improper actions taken by company officials. Recently, GSK reached an agreement with the United States Securities and Exchange Commission for allegations that GSK violated the... Continue reading
Posted Nov 11, 2016 at Policy and Medicine